Methods to improve the diagnostic accuracy of malignant mesothelioma
- 30 April 1996
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 90 (4) , 191-199
- https://doi.org/10.1016/s0954-6111(96)90286-3
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- The diagnostic implications of variable cytokeratin expression in mesotheliomasThe Journal of Pathology, 1993
- New strategies are needed in diffuse malignant mesotheliomaCancer, 1992
- Hyaluronan in pleural effusions and in serumCancer, 1991
- Immunocytochemical demonstration of collagen types I and IV in cells isolated from malignant mesothelioma and in lung cancer cell linesLung Cancer, 1990
- Use of antimesothelial cell antibody and computer assisted quantitative analysis for distinguishing between reactive and neoplastic serosal tissues.Journal of Clinical Pathology, 1987
- EXPERIENCE WITH THE OXFORD TUMOUR MARKER (Ca1) IN SEROUS FLUIDSThe Lancet, 1983
- USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONSThe Lancet, 1982
- A NEW MARKER FOR HUMAN CANCER CELLS. 1. THE Ca ANTIGEN AND THE Cal ANTIBODYThe Lancet, 1982
- Malignant mesothelioma of the pleura in Barrow-in-Furness.Thorax, 1978
- THE EFFECT OF DIGESTION WITH STREPTOMYCES HYALURONIDASE UPON CERTAIN HISTOCHEMICAL REACTIONS OF HYALURONIC ACID-CONTAINING TISSUESJournal of Histochemistry & Cytochemistry, 1973